Home
About Us
Knowledge
Products
Business
Newsroom
Careers
Contact Us
  • Home
  • About Us
    Company profile Corporate culture
  • Knowledge
    Drug instructions Literature Laws and regulations
  • Products
    All Drugs Medical Devices General products
  • Business
  • Newsroom
    Company news Media coverage
  • Careers
    Employing Recruit
  • Contact Us
    • NEWS CENTER
    Home Newsroom
    Company news
    Media coverage
  • 2021.10.21
    Faced with the "track congestion" of PD-1/PD-L1, a dialogue was held between pharmaceutical companies, doctors and regulatory authorities
    View all
  • 2021.08.24
    Novartis CAR-T therapy second-line treatment of B-NHL clinical study failed!
    View all
  • 2021.08.16
    It's fixed! Long prescription policy to select base drugs, nationally selected Chinese drugs and medical insurance drugs
    View all
  • 2021.08.13
    Centralized procurement of Chinese patent medicines and formula particles may start, starting with high-priced and large-volume varieties
    View all
  • 2021.08.02
    Forte Pharmaceuticals 2021H1 performance: revenue of 3.5 billion US dollars, less than 2 years after the approval of CF triple therapy, revenue is approaching 7 billion US dollars
    View all
  • 2021.07.26
    The demand for CDMO behind the hot ADC drugs
    View all
    • << < 12345 > >>